HB BESTPLEX Trademark

Trademark Overview


On Thursday, May 21, 2020, a trademark application was filed for HB BESTPLEX with the United States Patent and Trademark Office. The USPTO has given the HB BESTPLEX trademark a serial number of 88927496. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 11, 2021. This trademark is owned by HeimBiotek Inc.. The HB BESTPLEX trademark is filed in the Pharmaceutical Products category with the following description:

medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of BK virus infection or reactivation; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of kidney transplant rejection; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of Epstein-Barr virus infection; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of Cytomegalo virus infection; medical diagnostic kits consisting primarily of medical diagnostic reagents for prediction of targeted therapy efficacy for metastatic colorectal cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for prediction of targeted therapy efficacy for non-small cell lung cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for prognosis of liver ...
hb bestplex

General Information


Serial Number88927496
Word MarkHB BESTPLEX
Filing DateThursday, May 21, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements


Goods and Servicesmedical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of BK virus infection or reactivation; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of kidney transplant rejection; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of Epstein-Barr virus infection; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of Cytomegalo virus infection; medical diagnostic kits consisting primarily of medical diagnostic reagents for prediction of targeted therapy efficacy for metastatic colorectal cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for prediction of targeted therapy efficacy for non-small cell lung cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for prognosis of liver cancer after liver transplant; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of liver cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of pancreatic cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of lung cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of corona virus infection or reactivation; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of COVID-19 virus infection or reactivation
Pseudo MarkH B BEST PLEX

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHeimBiotek Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeongnamsi Gyeonggi-do 13486
KR

Party NameHeimBiotek Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeongnamsi Gyeonggi-do 13486
KR

Trademark Events


Event DateEvent Description
Tuesday, October 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 8, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, December 8, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 8, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, December 8, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, December 4, 2020ASSIGNED TO EXAMINER
Monday, June 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 25, 2020NEW APPLICATION ENTERED IN TRAM